Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 4, 2001, Pages 421-424

  Wang, Michael L H ^a   Yung, W K Alfred ^a   Royce, Melanie E ^a   Schomer, Donald F ^a   Theriault, Richard L ^a   Wogan, Christine F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Brain metastasis; Breast cancer; Capecitabine

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CAPECITABINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; HYDROXYUREA; LOMUSTINE; METHOTREXATE; PACLITAXEL; PROCARBAZINE; TAMOXIFEN; THALIDOMIDE; TIOGUANINE;

ADULT; ARTICLE; BRAIN CANCER; BRAIN METASTASIS; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; HUMAN; LYMPH NODE DISSECTION; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL;

ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; BREAST NEOPLASMS; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; MAGNETIC RESONANCE IMAGING; PRODRUGS;

EID: 0034903131     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200108000-00026     Document Type: Article

References (14)

1. Central nervous system metastasis from breast carcinoma: Autopsy study
2. Brain metastases from breast cancer: Clinical course, prognosis and influence of treatment
3. Radiation therapy for brain metastases
4. Chemotherapy of brain tumors: The "blood-brain barrier" is not a factor
5. Chemotherapy induces regression of brain metastases in breast carcinoma
6. Combination chemotherapy with CCNU, vincristine and methotrexate in primary and metastatic brain tumors
7. Tamoxifen-induced regression of cerebral metastases in breast carcinoma
8. Tamoxifen for brain metastases from breast cancer
9. Longterm remission of multiple brain metastases with tamoxifen
10. Clinical studies of the anticancer activity of FT-207
11. Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region
12. Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
13. A randomized phase II study of capecitabine vs. paclitaxel in breast cancer patients failing previous anthracycline therapy
14. A randomized phase II study of capecitabine vs. CMF as first-line chemotherapy of breast cancer in women aged > 55 years